MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-02-2026
AngioDynamics Operating Expenses 2011-2026 | ANGO
Annual Operating Expenses AngioDynamics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 198 M | 402 M | 225 M | 194 M | 192 M | 317 M | 157 M | 151 M | 151 M | 160 M | 159 M | 157 M | 147 M | 113 M | 114 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 402 M | 113 M | 189 M |
Quarterly Operating Expenses AngioDynamics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.4 M | 52.5 M | - | 48.8 M | 51 M | 49.8 M | - | 242 M | 53.4 M | 52.9 M | - | 49.4 M | 53.2 M | 55.6 M | 109 M | 43.9 M | 49.2 M | 48.2 M | 97.5 M | 42.3 M | 45 M | 40.9 M | 45 M | 40.9 M | 45 M | 39 M | 45 M | 39 M | 43.1 M | 42.1 M | 45.1 M | 44.1 M | 41.6 M | 41.1 M | 41.6 M | 41.1 M | 29.4 M | 41.5 M | 29.4 M | 41.5 M | 45.3 M | 43.2 M | 44.5 M | 42.1 M | 43.3 M | 43.7 M | 43.1 M | 42.6 M | 43.4 M | 41.2 M | 43.4 M | 41.2 M | 39 M | 41.2 M | 39 M | 38.8 M | 29.3 M | 29.4 M | 29.3 M | 29.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 242 M | 29.3 M | 48.5 M |
Operating Expenses of other stocks in the Medical instruments industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
39.8 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
1.23 B | $ 67.25 | 8.43 % | $ 13.4 B | USA |
 |
Glaukos Corporation
GKOS
|
482 M | $ 124.38 | 2.13 % | $ 7.11 B | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
7.99 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
3.7 B | $ 424.83 | 1.43 % | $ 152 B | USA |
 |
Alcon
ALC
|
3.37 B | $ 66.78 | 0.33 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
779 M | $ 136.94 | 1.49 % | $ 3.37 B | USA |
 |
iRhythm Technologies
IRTC
|
585 M | $ 108.01 | 0.61 % | $ 3.46 B | USA |
 |
Repro Med Systems
KRMD
|
28.6 M | $ 4.0 | -3.48 % | $ 185 M | USA |
 |
LeMaitre Vascular
LMAT
|
111 M | $ 95.15 | 1.7 % | $ 2.15 B | USA |
 |
Masimo Corporation
MASI
|
1.27 B | $ 178.93 | 0.01 % | $ 9.54 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
72.9 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
388 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Microbot Medical
MBOT
|
9.09 K | $ 1.84 | -6.38 % | $ 84.3 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
20.2 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
12.1 M | $ 0.4 | -8.16 % | $ 32.8 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.05 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
40.9 M | $ 8.74 | -12.1 % | $ 74.1 K | USA |
 |
Envista Holdings Corporation
NVST
|
2.27 B | $ 23.06 | 0.85 % | $ 3.87 B | USA |
 |
Haemonetics Corporation
HAE
|
631 M | $ 71.24 | 2.03 % | $ 3.36 B | USA |
 |
STERIS plc
STE
|
1.52 B | $ 213.28 | 0.47 % | $ 20.9 B | USA |
 |
Isoray
ISR
|
114 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
100 M | $ 29.67 | -0.64 % | $ 1.47 B | USA |
 |
InfuSystem Holdings
INFU
|
68.4 M | $ 9.26 | 1.54 % | $ 191 M | USA |
 |
Teleflex Incorporated
TFX
|
1.05 B | $ 130.93 | -0.86 % | $ 5.84 B | USA |
 |
Utah Medical Products
UTMD
|
11.8 M | $ 68.72 | 1.08 % | $ 223 M | USA |
 |
Merit Medical Systems
MMSI
|
554 M | $ 64.42 | 2.19 % | $ 3.81 B | USA |
 |
West Pharmaceutical Services
WST
|
301 M | $ 317.27 | - | $ 22.9 B | USA |
 |
Pulse Biosciences
PLSE
|
48 M | $ 25.21 | -6.42 % | $ 1.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.72 B | $ 9.93 | 0.46 % | $ 1.98 B | USA |
 |
Retractable Technologies
RVP
|
21.2 M | $ 0.66 | -0.05 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
8.82 M | $ 66.56 | -0.66 % | $ 219 M | USA |
 |
Predictive Oncology
POAI
|
10.3 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
17.8 M | $ 26.76 | -1.22 % | $ 1.28 B | USA |
 |
Stereotaxis
STXS
|
39.2 M | $ 1.79 | -5.05 % | $ 163 M | USA |
 |
Baxter International
BAX
|
3.88 B | $ 19.5 | 0.75 % | $ 10 B | USA |
 |
ResMed
RMD
|
1.02 B | $ 195.76 | 0.75 % | $ 28.6 B | USA |
 |
AtriCure
ATRC
|
410 M | $ 27.17 | -0.37 % | $ 1.3 B | USA |
 |
Harvard Bioscience
HBIO
|
98.5 M | $ 6.16 | -5.02 % | $ 273 M | USA |
 |
NeuroMetrix
NURO
|
10.5 M | - | 5.05 % | $ 9.02 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.05 B | $ 153.05 | 2.39 % | $ 44 B | USA |
 |
Nephros
NEPH
|
10.5 M | $ 3.44 | -4.32 % | $ 36.5 M | USA |
 |
OraSure Technologies
OSUR
|
120 M | $ 4.05 | -2.88 % | $ 298 M | USA |
 |
Repligen Corporation
RGEN
|
115 M | $ 122.69 | -3.05 % | $ 6.9 M | USA |